Explore evidence

80.5 %Recognition of the SARS-CoV-2 proteins by sera from COVID-19 patients was 80.5% for S, 71.1% for RBD, and 31.9% for RBM.

MaliCOVID-19HAL · Unilimdocument of 67 observations

71.9 %The RBD showed comparable antibody responses of 71.9% to the full-length S protein, which had an antibody response of 80.5%.

MaliCOVID-19HAL · Unilimdocument of 67 observations

36 %36% of individuals in the PIP profile avoided seeing friends.

MaliCOVID-19HAL · Unilimdocument of 88 observations

33 %33% of individuals in the INO profile strongly agreed that COVID-19 was a divine punishment.

MaliCOVID-19HAL · Unilimdocument of 88 observations

16 %Only 16% of individuals in the PIP profile were aware of the symptoms of COVID-19.

MaliCOVID-19HAL · Unilimdocument of 88 observations

2.9 %Only 2.9% of individuals in the MIM profile never wore a mask outdoors.

MaliCOVID-19HAL · Unilimdocument of 88 observations

34.2 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against RBM was 34.2% among females.

MaliCOVID-19 · SARS-CoV-2 RBMHAL · Unilimdocument of 67 observations

71.1 %Recognition of the SARS-CoV-2 proteins by sera from COVID-19 patients was 71.1% for RBD.

MaliCOVID-19HAL · Unilimdocument of 67 observations

80.5 %The full-length S protein showed an antibody response of 80.5%.

MaliCOVID-19HAL · Unilimdocument of 67 observations

715 décèsAu 31 janvier 2022, 715 décès liés au COVID-19 avaient été signalés au Mali.

MaliCOVID-19observed 31 janvier 2022HAL · Unilimdocument of 36 observations

9 deathsThe officially reported number of COVID-19 deaths in Tombouctou was 9.

MaliCOVID-19HAL · Unilimdocument of 88 observations

21.9 %Cross-reactivity against the SARS-CoV-2 S antigen was as high as 21.9% among populations not infected with SARS-CoV-2 living in malaria-endemic areas.

MaliCOVID-19 · paludismeHAL · Unilimdocument of 67 observations

9,941 patientsBetween July 2022 and October 2023, a total of 9941 patients with severe respiratory illness were enrolled, of whom 588 (5.9%) tested positive for SARS-CoV-2.

Kenya · MaliCOVID-19observed July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations

Seroprevalence of SARS-CoV-2 was higher among people from traditionally wealth households in Tombouctou.

MaliCOVID-19HAL · Unilimdocument of 88 observations

31.9 %Among 266 COVID-19 donor samples, 85 (31.9%) recognized the RBM protein.

MaliCOVID-19HAL · Unilimdocument of 67 observations

33,160 casesIn November 2023, Mali officially recorded 33,160 confirmed COVID-19 cases.

MaliCOVID-19observed November 2023HAL · Unilimdocument of 88 observations

2 %L'accès aux structures de santé pour le test COVID-19 après référence par les agents de santé communautaires était de 2 % (10 sur 449 patients).

MaliCOVID-19observed 2022HAL · Unilimdocument of 36 observations

0.8 %The reported incidence of SARS-CoV-2 in the urban commune of Tombouctou was 0.8% during January 2021.

MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations

71.9 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against RBD was 71.9% among males.

MaliCOVID-19 · SARS-CoV-2 RBDHAL · Unilimdocument of 67 observations

58 %Dans l'étude ECoVAM menée d'octobre 2021 à janvier 2022 au Mali, 58 % des patients recrutés (1 405 sur 2 347) présentaient des symptômes cliniques évocateurs de COVID-19.

MaliCOVID-19observed octobre 2021 à janvier 2022HAL · Unilimdocument of 36 observations

11 daysAt least 11–14 days after the onset of the disease is reported to be necessary to observe an average seroconversion rate of approximately 90%–100% for antibodies (IgM or IgG) against the SARS-CoV-2 S and N proteins.

MaliCOVID-19HAL · Unilimdocument of 67 observations

9 deathsThere were 9 declared deaths caused by COVID-19 compared to approximately 156 expected deaths in the urban commune of Tombouctou.

MaliCOVID-19HAL · Unilimdocument of 88 observations

2.08 R0The estimated R0 of the COVID-19 infection in Tombouctou was 2.08 [1.46–2.93].

MaliCOVID-19HAL · Unilimdocument of 88 observations

5.9 %Between July 2022 and October 2023, 588 out of 9941 patients with severe respiratory illness tested positive for SARS-CoV-2, corresponding to a positivity rate of 5.9%.

Kenya · MaliCOVID-19observed July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations

4.9 %4.9% of individuals in the PIP profile strongly agreed that COVID-19 was introduced by white people.

MaliCOVID-19HAL · Unilimdocument of 88 observations